TMCI
TREACE MEDICAL CONCEPTS, INC.
+0.01 (+0.11%)4.57USD57.1K成交股數297M市值–本益比(近四季)1.4股價營收比-4.2%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 45.4M-4% | 47.2M-10% | – | 50.2M+11% | 47.4M+7% | 52.6M+3% | – | 45.1M+7% | 44.5M | 51.1M | 40.8M | 42.0M |
| 營業成本 | 9.8M | 9.8M | – | 10.5M | 9.6M | 10.7M | – | 9.0M | 8.8M | 10.1M | 8.0M | 7.7M |
| 毛利 | 35.6M-6% | 37.4M-11% | – | 39.7M+10% | 37.8M+6% | 41.9M+2% | – | 36.1M+5% | 35.7M | 41.0M | 32.8M | 34.3M |
| 毛利率 | 78.5% | 79.3% | – | 79.1% | 79.7% | 79.7% | – | 80.1% | 80.2% | 80.2% | 80.4% | 81.7% |
| 研發費用 | 4.4M | 4.6M | – | 4.7M | 5.5M | 5.6M | – | 5.0M | 5.2M | 5.3M | 4.4M | 3.5M |
| 銷售管理費用 | 15.2M | 16.2M | – | 16.3M | 16.1M | 15.8M | – | 13.5M | 14.2M | 14.4M | 12.7M | 10.0M |
| 營業利益 | −15.0M-12% | −17.2M+10% | – | −15.7M+4% | −17.0M-21% | −15.6M-18% | – | −15.1M+16% | −21.4M | −19.0M | −17.8M | −13.1M |
| 營業利益率 | -33.0% | -36.4% | – | -31.2% | -35.8% | -29.6% | – | -33.6% | -48.1% | -37.1% | -43.7% | -31.1% |
| 稅後淨利 | −15.9M-9% | −18.0M+13% | −9.4M+1775% | −16.3M+6% | −17.4M-18% | −15.9M-15% | −501K-97% | −15.4M+25% | −21.2M | −18.7M | −17.5M | −12.3M |
| 淨利率 | -35.0% | -38.1% | – | -32.4% | -36.7% | -30.3% | – | -34.1% | -47.7% | -36.5% | -43.0% | -29.2% |
| 稀釋 EPS | -0.24-14% | -0.28+12% | – | -0.26+4% | -0.28-18% | -0.25-17% | – | -0.25+25% | -0.34 | -0.30 | -0.28 | -0.20 |
| 稀釋股數 | 65.0M | 64.6M | – | 63.5M | 63.0M | 62.7M | – | 62.2M | 62.1M | 61.8M | 61.6M | 61.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 12.6M | 9.5M | 10.7M | 7.7M | 8.1M | 13.4M | 11.4M | 12.1M | 18.2M | 9.3M | 7.3M | 12.0M |
| 應收帳款 | 28.7M | 30.4M | 42.2M | 33.0M | 30.3M | 31.1M | 40.8M | 24.2M | 25.6M | 30.1M | 25.0M | 27.2M |
| 存貨 | 39.5M | 36.4M | 36.0M | 41.4M | 42.4M | 37.9M | 39.3M | 43.6M | 41.3M | 35.9M | 29.3M | 26.1M |
| 總資產 | 181M | 184M | 191M | 197M | 206M | 206M | 217M | 213M | 226M | 243M | 240M | 250M |
| 有息負債 | 56.0M | 55.8M | 55.6M | 53.5M | 53.5M | 53.4M | 53.3M | 53.2M | 53.2M | 53.1M | 52.9M | 52.9M |
| 總負債 | 113M | 107M | 103M | 107M | 109M | 101M | 104M | 108M | 114M | 116M | 103M | 99.7M |
| 股東權益 | 67.7M | 77.2M | 87.3M | 89.2M | 97.6M | 105M | 113M | 105M | 112M | 126M | 138M | 150M |
| 負債比 | 62.6% | 58.1% | 54.2% | 54.6% | 52.7% | 48.8% | 48.0% | 50.7% | 50.4% | 47.9% | 42.6% | 39.9% |
| 淨現金(現金 − 有息負債) | −43.4M | −46.3M | −44.9M | −45.8M | −45.4M | −40.0M | −42.0M | −41.1M | −35.0M | −43.7M | −45.7M | −40.8M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 7.2M+72% | – | – | – | 4.2M-158% | – | – | – | −7.2M | – | – |
| 資本支出 | – | 3.1M | – | – | – | 3.5M | – | – | – | 3.9M | – | – |
| 自由現金流 | – | 4.2M+538% | – | – | – | 655K-106% | – | – | – | −11.1M | – | – |
| 折舊攤銷 | – | 899K | 2.8M | – | – | 2.5M | 2.2M | – | – | 1.9M | – | 1.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 8.9% | – | – | – | 1.2% | – | – | – | -21.8% | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 213M | +1.6% | −59.0M | -27.7% | -0.93 | −29.5M |
| FY2024 | 209M | +11.9% | −55.7M | -26.6% | -0.90 | −48.8M |
| FY2023 | 187M | +31.9% | −50.0M | -26.7% | -0.81 | −46.0M |
| FY2022 | 142M | +50.2% | −43.0M | -30.3% | -0.77 | −45.5M |
| FY2021 | 94.4M | +64.6% | −20.6M | -21.8% | -0.43 | −19.9M |
| FY2020 | 57.4M | +45.5% | −3.7M | -6.4% | -0.12 | −5.6M |
| FY2019 | 39.4M | – | −4.3M | -10.8% | -0.13 | −8.9M |